Trial intelligence / Profile preview

Fresh Frozen Plasma vs Albumin for Large Volume Paracentesis

NCT03202524Phase 4Withdrawn

Sponsor
Montefiore Medical Center
Start
Dec 2017
Primary completion
Jul 2018
Modality
Recombinant Proteins and Enzymes, Tissue Cells
01

Overview

Phase 4, randomised, open-label trial of fresh-frozen plasma in ascites and Liver cirrhosis (LC) (2 arms), sponsored by Montefiore Medical Center. Primary endpoint: Incidence of Post-Paracentesis Circulatory Dysfunction at 6 days. Planned start Dec 2017; status: withdrawn.

02

Drugs

fresh-frozen plasma
03

Conditions

ascitesLiver cirrhosis (LC)

Beyond the preview

Go deeper on NCT03202524.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03202524.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call